Skip to the page

Data / Drug companies / Medsource Pharmaceuticals

Medsource Pharmaceuticals: 20 products in the FDA NDC directory, labeler code 45865

Medsource Pharmaceuticals (labeler code 45865) lists 20 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 20 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 15, 2022.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
45865
Products in commercial distribution
20
Packages
36
Finished drugs by generic name
17
Prescription products
20
Over the counter products
0
Controlled substance products
Schedule IV 4
Started marketing in the last 12 months
0
Earliest marketing start
May 1, 2003
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)20100%

Products by type

TypeProductsShare
Prescription drugs20100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet840%
Tablet, film coated525%
Capsule420%
Capsule, delayed release15%
Gel15%
Tablet, extended release15%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Diclofenac Sodium45865-260GelGeneric drugs (ANDA)September 15, 2022
Prednisone45865-884TabletGeneric drugs (ANDA)September 1, 2021
Celecoxib45865-234CapsuleGeneric drugs (ANDA)December 3, 2020
Naproxen45865-238TabletGeneric drugs (ANDA)March 1, 2020
Carisoprodol45865-233TabletGeneric drugs (ANDA)January 20, 2020
Methocarbamol45865-242TabletGeneric drugs (ANDA)August 15, 2019
Gabapentin45865-216CapsuleGeneric drugs (ANDA)May 14, 2018
Trazodone Hydrochloride45865-167TabletGeneric drugs (ANDA)December 11, 2017
Tramadol Hydrochloride and Acetaminophen45865-170Tablet, film coatedGeneric drugs (ANDA)March 22, 2017
Amoxicillin and Clavulanate Potassium45865-230Tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Amoxicillin and clavulanate potassium45865-227Tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Gabapentin45865-194CapsuleGeneric drugs (ANDA)February 18, 2016
Esomeprazole Magnesium45865-163Capsule, delayed releaseGeneric drugs (ANDA)December 10, 2015
Alprazolam45865-257TabletGeneric drugs (ANDA)July 31, 2015
Fluoxetine45865-174CapsuleGeneric drugs (ANDA)March 16, 2015
Hydroxyzine hydrochloride45865-675TabletGeneric drugs (ANDA)August 20, 2014
Tramadol hydrochloride45865-184Tablet, extended releaseGeneric drugs (ANDA)August 19, 2014
Trazodone Hydrochloride45865-505TabletGeneric drugs (ANDA)November 27, 2013
Cyclobenzaprine Hydrochloride45865-244Tablet, film coatedGeneric drugs (ANDA)September 26, 2008
Etodolac45865-206Tablet, film coatedGeneric drugs (ANDA)May 1, 2003

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.